Outcomes of various classes of oral antidiabetic drugs on nonalcoholic fatty liver disease
Jang H, Kim Y, Lee DH, et al.
JAMA Intern Med. 2024;184(4):375-383.
Leggi
Jang H, Kim Y, Lee DH, et al.
JAMA Intern Med. 2024;184(4):375-383.
Leggi
Dennison RA, Oliver-Williams C, Qi HLJ, et al.
Diabet Med. Pub. Online 29 Mar 2024.
Leggi
Rodbard HW, Barnard-Kelly K, Pfeiffer AFH, et al.
Diabetes Obes Metab. Pub. Online 21 Mar 2024.
Leggi
Abdelmalek MF, Harrison SA, Sanyal AJ
Diabetes Obes Metab. Pub. Online 21 Mar 2024.
Leggi
Giorgino F, Franco DR, Nicolay C, et al.
Diabetes Care. Pub. Online 26 Mar 2024.
Leggi
Gilliam LK, Parker MM, Moffet HH, et al.
Diabetes Technol Ther. Pub. Online 22 Mar 2024.
Leggi
Gao V, Snell-Bergeon JK, Malecha E, et al.
Diabetes Technol Ther. Pub. Online 25 Mar 2024.
Leggi
Fagerberg AR, Borch L, Kristensen K, Hjelle JS
Diabetes Technol Ther. Pub. Online 25 Mar 2024.
Leggi
Zhang J, Na X, Li Z, et al.
BMC Med. 2024;22(1):133.
Leggi
White B, Ng SM, Agwu JC, et al.
BMC Med. 2024;22(1):144.
Leggi